Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases
Klinische Pädiatrie · 01.07.2026 · 238 (04) · 191-195
DOI: 10.1055/a-2367-9190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.07.2026. Verfasst von Lala Nurmammadova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics, Bezmialem Vakif University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Myocarditis, Neopterin. Die Arbeit nennt 26 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
The most important cause of mortality and morbidity in acute rheumatic fever (ARF) is carditis and rheumatic heart disease (RHD). The aim of this study was to identify markers that may be indicators of chronic inflammation in whole blood analyses in pediatric patients with RHD who regularly received secondary deposilin prophylaxis.
Methods
In our study, 100 children with ARF aged between 4 and 18 years were followed up in the pediatric cardiology outpatient clinic of the patient group. The control group consisted of 100 healthy children of the same sex and age as the patient group. All children in the patient group regularly received deposilin prophylaxis every 21 days. Our study included many whole blood parameters that are reported in the literature to represent changes in chronic inflammatory diseases. These parameters were CRP, RDW, PDW, MPV and leukocyte subtypes, neutrophil, lymphocyte, monocyte counts and their ratios (neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte).
Results
Leukocyte count, lymphocyte count, basophil count, MLR and basophil count were significantly lower in the patient group than in the control group (p: 0.047, p: 0.023, p: 0.006). In addition, eosinophil count and RDW value were significantly higher in the patient group than in the control group (p: 0.043; p: 0.001).
Conclusion
In our study, low leukocyte, lymphocyte, basophil, MLR and higher eosinophil counts indicated that RDW could be effectively used as a marker for regular depositilin prophylaxis in pediatric patients with RHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatrics, Bezmialem Vakif University, Istanbul, Turkey.
- Pediatric Cardiology, Istanbul Medipol University, Istanbul, Turkey.
- Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
- Biostaticts, National Statistical Systems Training Academy, Istanbul, Turkey.
- Pediatrics, Istanbul Medipol University, Istanbul, Turkey.
ORCID-Profile: Can Yilmaz Yozgat
Zitieren
APA
Nurmammadova, L., Yozgat, Y., Yozgat, C. Y., Babayeva, T., Bayramova, N., Talebazadeh, F., Koç, E., Kahraman, F. U., & Erenberk, U. (2026). Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases. Klinische Pädiatrie, 238(04), 191-195. https://doi.org/10.1055/a-2367-9190
Vancouver
Nurmammadova L, Yozgat Y, Yozgat CY, Babayeva T, Bayramova N, Talebazadeh F, et al. Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases. Klinische Pädiatrie. 2026;238(04):191-195. doi:10.1055/a-2367-9190
BibTeX
@article{Nurmammadova2026,
author = {Nurmammadova, Lala and Yozgat, Yilmaz and Yozgat, Can Yilmaz and Babayeva, Turkay and Bayramova, Nigar and Talebazadeh, Faraz and Koç, Ertan and Kahraman, Feyza Ustabas and Erenberk, Ufuk},
title = {Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases},
journal = {Klinische Pädiatrie},
year = {2026},
volume = {238},
number = {04},
pages = {191--195},
doi = {10.1055/a-2367-9190}
}
EUVIMED